MICHELLE KING-CHRISMAN: Open Payments
NPI 1104120518 · ARVADA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 14 payments from 10 companies in 2025. Trend: 2023 $580 · 2024 $628 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $118 |
| PFIZER INC. | 4 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Exact Sciences Corporation | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| SI-BONE, INC. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
Products named: Wegovy, NURTEC ODT, Kerendia, ZAVZPRET, Cologuard Collection Kit, Symbravo, Tirosint, EVENITY.
Industry payments across CO — which companies pay providers there.
